Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Clinical trial NCT02489344 · COMPLETED
Trial details
- NCT number
- NCT02489344
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-07
- Primary completion
- 2018-11-20
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.